Red Lion Hotels Corporation (NYSE:RLH) has a beta value of 1.24 and has seen 3,034,478 shares traded in the last trading session. The company, currently valued at $61.83 Million, closed the last trade at $2.44 per share which meant it gained $0.44 on the day or 22% during that session. The RLH stock price is -202.87% off its 52-week high price of $7.39 and 52.46% above the 52-week low of $1.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 656.58 Million shares traded. The 3-month trading volume is 292.43 Million shares.
The consensus among analysts is that Red Lion Hotels Corporation (RLH) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.27.
Red Lion Hotels Corporation (NYSE:RLH) trade information
Sporting 22% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jun 26 when the RLH stock price touched $2.79-1 or saw a rise of 12.54%. Year-to-date, Red Lion Hotels Corporation shares have moved -34.58%, while the 5-day performance has seen it change 22%. Over the past 30 days, the shares of Red Lion Hotels Corporation (NYSE:RLH) have changed 34.07%. Short interest in the company has seen 2.08 Million shares shorted with days to cover at 0.01.
Wall Street analysts have a consensus price target for the stock at $3.5, which means that the shares’ value could jump 43.44% from current levels. The projected low price target is $3.5 while the price target rests at a high of $3.5. In that case, then, we find that the current price level is +43.44% off the targeted high while a plunge would see the stock lose 43.44% from current levels.
Red Lion Hotels Corporation (RLH) estimates and forecasts
Figures show that Red Lion Hotels Corporation shares have underperformed across the wider relevant industry. The company’s shares have lost -33.33% over the past 6 months, with this year growth rate of NA%, compared to NA% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -145.5% and 21.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be -39.6%.
1 analysts offering their estimates for the company have set an average revenue estimate of $13.86 Million for the current quarter. 1 have an estimated revenue figure of $19.13 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $30.06 Million and $33.36 Million respectively for this quarter and the next, and analysts expect sales will grow by -53.9% for the current quarter and -42.7% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -51.9% over the past 5 years. Earnings growth for 2020 is a modest -5.3% while over the next 5 years, the company’s earnings are expected to increase by 30%.